heparin sodium
Drug ingredientActive ShortageThis drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.
Where It Comes From
49 FDA-registered drug labelers
Amphastar Nanjing Pharmaceuticals, Inc.
ANIMEX FOODS SP Z O O ODDZIAL W STARACHOWICACH
Aspen Oss B.V.
B. Braun Medical Inc.
Baxter Healthcare Corporation
BE Pharmaceuticals Inc.
BioChem Oss
Biofer, SpA
Bioiberica SAU
Biopharmacotech Sp z o o Spolka Komandytowa
Canada Packers Inc.
Cardinal Health 107, LLC
CHANGZHOU QIANHONG BIO PHARMA CO LTD
Civica, Inc.
DARMERICA, LLC
Fresenius Kabi USA, LLC
Gland Pharma Limited
Haotai Health Jisheng (Jilin) Biotechnology Co., Ltd.
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
Henry Schein, Inc.
Hepac B.V.
Hepalink USA Inc.
HF Acquisition Co LLC, DBA HealthFirst
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Hubei Enoray Biopharmaceutical Co., Ltd.
Luohe Huisheng Bio-tech Co.,Ltd.
McKesson Corporation dba SKY Packaging
Medical Purchasing Solutions, LLC
Meitheal Pharmaceuticals Inc.
Mobren Transport, Inc.
Mylan Institutional LLC
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
NorthStar RxLLC
Olymel
Pfizer Laboratories Div Pfizer Inc
Pharmacia Hepar LLC
Phlow Corporation
Plano Pharmaceuticals Inc.
Professional Compounding Centers of America
Qingdao Jiulong Biopharmaceutical Co., Ltd.
REMEDYREPACK INC.
Sagent Pharmaceticals
Sagent Pharmaceuticals
Sandoz Inc.
Scientific Protein Laboratories LLC
Shenzhen Hepalink Pharmaceutical Group Co.,Ltd.
Smithfield Bioscience, Inc.
Yantai Dongcheng Biochemicals Co.,Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 4 drug and cosmetic product listings (FDA).
- •Heparin Sodium
- •Heparin Sodium and Dextrose
- •Heparin Sodium in Dextrose
- •Heparin Sodium in Sodium Chloride
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
Active Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
current
Heparin Sodium Injection
11/14/2017Unavailable
current
Heparin Sodium Injection
11/14/2017Available
current
Heparin Sodium Injection
11/14/2017Limited Availability
Chemical Identity
CAS9041-08-1
PubChem CID92044406
DTXSIDDTXSID301010914
FormulaC26H42N2NaO37S5+
Mol. Weight1157.9 g/mol
SMILESCC(=O)NC1C(C(C(OC1O)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)CO)OC4C(C(C(C(O4)C(=O)O)O)O)OS(=O)(=O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O.[Na+]
Data Sources
920444062026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/heparin sodium/cids/JSON
Archive: data/sources/pubchem_name/heparin sodium.json
CAS 9041-08-12026-04-24
https://www.epa.gov/tsca-inventory
Archive: data/sources/tsca/tsca_inventory.csv
CAS 9041-08-12026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json